3.14
price down icon6.55%   -0.22
after-market After Hours: 3.03 -0.11 -3.50%
loading
Immunitybio Inc stock is traded at $3.14, with a volume of 8.70M. It is down -6.55% in the last 24 hours and up +9.79% over the past month.
See More
Previous Close:
$3.36
Open:
$3.41
24h Volume:
8.70M
Relative Volume:
1.47
Market Cap:
$2.87B
Revenue:
$1.31M
Net Income/Loss:
$-597.65M
P/E Ratio:
-3.2371
EPS:
-0.97
Net Cash Flow:
$-425.62M
1W Performance:
+15.87%
1M Performance:
+9.79%
6M Performance:
-20.10%
1Y Performance:
-41.53%
1-Day Range:
Value
$3.02
$3.47
1-Week Range:
Value
$2.69
$3.47
52-Week Range:
Value
$2.28
$10.53

Immunitybio Inc Stock (IBRX) Company Profile

Name
Name
Immunitybio Inc
Name
Phone
(844) 696-5235
Name
Address
3530 JOHN HOPKINS COURT, SAN DIEGO
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
IBRX's Discussions on Twitter

Compare IBRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IBRX
Immunitybio Inc
3.14 2.87B 1.31M -597.65M -425.62M -0.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-06-25 Initiated H.C. Wainwright Buy
Jan-10-25 Initiated BTIG Research Buy
May-12-23 Downgrade Piper Sandler Overweight → Neutral
Aug-03-22 Initiated Jefferies Buy

Immunitybio Inc Stock (IBRX) Latest News

pulisher
Mar 26, 2025

ImmunityBio to Host Investor Day - BioSpace

Mar 26, 2025
pulisher
Mar 25, 2025

Is ImmunityBio, Inc. (NASDAQ:IBRX) The Top Penny Stock That Will Skyrocket? - Insider Monkey

Mar 25, 2025
pulisher
Mar 24, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates - EIN News

Mar 24, 2025
pulisher
Mar 19, 2025

ImmunityBio appoints Deloitte as new auditor By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

ImmunityBio appoints Deloitte as new auditor - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Drugmaker's $10.5M Deal In Investor FDA Approval Suit OK'd - Law360

Mar 18, 2025
pulisher
Mar 18, 2025

ImmunityBio $10.5 Million Settlement Over Record Selloff Gets OK - Bloomberg Law

Mar 18, 2025
pulisher
Mar 18, 2025

From cancer vaccines to COPD treatments, these 10 companies are developing innovative medicines - Fast Company

Mar 18, 2025
pulisher
Mar 17, 2025

ImmunityBio ($IBRX) Is Paying a $10.5M Settlement to Investors — Here’s How to Get Your Share - TradingView

Mar 17, 2025
pulisher
Mar 14, 2025

H.C. Wainwright maintains $8 target for ImmunityBio stock By Investing.com - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

H.C. Wainwright maintains $8 target for ImmunityBio stock - Investing.com

Mar 14, 2025
pulisher
Mar 13, 2025

Recombinant BCG Vaccine Becomes Available in the U.S. - Precision Vaccinations

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching - BioSpace

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunityBio Partner US Urology Begins Administering rBCG to Address Tice BCG Shortage - Marketscreener.com

Mar 13, 2025
pulisher
Mar 12, 2025

ImmunityBio, Inc. (IBRX): Among the Stocks Under $10 With High Upside Potential - Insider Monkey

Mar 12, 2025
pulisher
Mar 11, 2025

ImmunityBio (IBRX) Expected to Announce Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

SBI Securities Co. Ltd. Buys New Position in ImmunityBio, Inc. (NASDAQ:IBRX) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Q1 Earnings Forecast for ImmunityBio Issued By HC Wainwright - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Private Advisor Group LLC Cuts Stock Position in ImmunityBio, Inc. (NASDAQ:IBRX) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

HC Wainwright Begins Coverage on ImmunityBio (NASDAQ:IBRX) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

ImmunityBio: BCG Shortage And Tariff Risks Could Stifle Anktiva's Commercial Momentum - Seeking Alpha

Mar 07, 2025
pulisher
Mar 07, 2025

H.C. Wainwright sets $8 target for ImmunityBio stock, rates Buy By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 06, 2025

ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug - Benzinga India

Mar 06, 2025
pulisher
Mar 06, 2025

This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga India

Mar 06, 2025
pulisher
Mar 06, 2025

H.C. Wainwright sets $8 target for ImmunityBio stock, rates Buy - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

HC Wainwright Initiates Coverage on ImmunityBio With Buy Rating, $8 Price Target -March 06, 2025 at 07:26 am EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

HC Wainwright & Co. Initiates Coverage of ImmunityBio (IBRX) with Buy Recommendation - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

H.C. Wainwright starts coverage of ImmunityBio with 'buy' rating - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

Earnings Update: ImmunityBio, Inc. (NASDAQ:IBRX) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts - Simply Wall St

Mar 06, 2025
pulisher
Mar 06, 2025

New York State Common Retirement Fund Grows Position in ImmunityBio, Inc. (NASDAQ:IBRX) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

ImmunityBio (NASDAQ:IBRX) Trading Up 6.8% Following Strong Earnings - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Why ImmunityBio Inc. (IBRX) Crashed on Monday - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

ImmunityBio Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

ImmunityBio: Q4 Earnings Snapshot - Barchart

Mar 04, 2025
pulisher
Mar 04, 2025

ImmunityBio, Inc. (NASDAQ:IBRX) Shares Bought by Handelsbanken Fonder AB - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

ImmunityBio’s Sales Surge Amid Strategic Advances - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

ImmunityBio stock rises on Q4 earnings beat, revenue growth - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Why ImmunityBio, Inc. (IBRX) Soared on Friday - MSN

Mar 03, 2025
pulisher
Mar 03, 2025

ImmunityBio stock rises on Q4 earnings beat, revenue growth By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

Immunitybio Inc earnings beat by $0.08, revenue topped estimates - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

ImmunityBio (IBRX) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 03, 2025
pulisher
Mar 03, 2025

ImmunityBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Mar 03, 2025

Immunitybio Inc Stock (IBRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
Cap:     |  Volume (24h):